Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Alkermes Plc
(NQ:
ALKS
)
27.88
-0.16 (-0.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Alkermes Plc
< Previous
1
2
3
4
5
6
7
8
Next >
7 Healthcare Stocks That Are Poised to Become the Next Unicorns
November 09, 2023
Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.
Via
InvestorPlace
For those who appreciate growth without the sticker shock, NASDAQ:ALKS is worth considering.
November 07, 2023
ALKERMES PLC (NASDAQ:ALKS) stands out as a growth opportunity that won't break the bank.
Via
Chartmill
NASDAQ:ALKS, an undervalued stock with good fundamentals.
October 26, 2023
ALKERMES PLC (NASDAQ:ALKS) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via
Chartmill
Why Alkermes Stock Is Sinking Today
October 25, 2023
The biotech company's Q3 revenue and earnings looked great, but the results weren't enough to wow investors.
Via
The Motley Fool
Alkermes Q3 Earnings Top Consensus, On Track To Separate Oncology Business, Reaffirms FY23 Outlook
October 25, 2023
Alkermes PLC (NASDAQ: ALKS) reported Q3 FY23 adjusted EPS of $0.64 compared to $0.02 a year ago, beating the
Via
Benzinga
Alkermes Plummets In Huge Volume. Why One Analyst Says The Reaction Is Overdone.
October 23, 2023
Analysts say Alkermes' drug is clearly active. But investors have concerns.
Via
Investor's Business Daily
Why NASDAQ:ALKS Is a Promising High-Growth Stock in the Midst of Consolidation.
October 23, 2023
ALKERMES PLC (NASDAQ:ALKS), a strong growth stock, setting up for a breakout.
Via
Chartmill
Earnings Preview: Alkermes
July 25, 2023
Via
Benzinga
Where Alkermes Stands With Analysts
June 07, 2023
Via
Benzinga
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 25, 2023
Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.
Via
Benzinga
While growth is established for NASDAQ:ALKS, the stock's valuation remains reasonable.
October 17, 2023
Looking for growth without the hefty price tag? Consider ALKERMES PLC (NASDAQ:ALKS).
Via
Chartmill
Alkermes Earnings Perspective: Return On Capital Employed
April 27, 2023
Via
Benzinga
Analyst Expectations for Alkermes's Future
April 27, 2023
Via
Benzinga
The Latest Analyst Ratings for Alkermes
April 27, 2023
Via
Benzinga
A Preview Of Alkermes's Earnings
April 25, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
October 24, 2023
Via
Benzinga
NASDAQ:ALKS is showing good growth, while it is not too expensive.
September 26, 2023
Despite its growth, ALKERMES PLC (NASDAQ:ALKS) remains within the realm of affordability.
Via
Chartmill
Hovnanian Enterprises, LexinFintech Holdings And Other Big Stocks Moving Higher On Wednesday
August 30, 2023
U.S. stocks traded mixed, with the Dow Jones falling around 10 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Earnings Scheduled For February 16, 2023
February 16, 2023
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year...
Via
Benzinga
Alkermes Earnings Preview
February 15, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
October 17, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
August 17, 2023
Via
Benzinga
3 Top Biotech Stocks Defying the Bear Market
August 10, 2023
Biotech is still booming, if you pick the right biotech stocks.
Via
The Motley Fool
Alkermes Clocks Over 100% Jump In Q2 Sales and Profits On Reinstated Product Royalty From Long-Acting Invega
July 26, 2023
Alkermes plc (NASDAQ: ALKS) reported Q2 adjusted EPS of $0.55 compared to $0.06 a year ago, missing the consensus of $0.56
Via
Benzinga
Alkermes Raises FY23 Outlook Following Arbitration Award from Janssen Agreements
June 06, 2023
Via
Benzinga
Alkermes Stock Sees Rising Relative Strength Rating
March 28, 2023
The Relative Strength (RS) Rating for Alkermes stock climbed into a new percentile Tuesday, as it got a lift from 69 to 77.
Via
Investor's Business Daily
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
March 15, 2023
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.
Via
InvestorPlace
Alkermes: Commercialization Program On Track, Sales Coming In Strong
March 04, 2023
The bigger biotechs have done a good job lately, with solid earnings to date. Speaking of which, Alkermes plc has recently exceeded estimates. Let's take a closer look at the company's performance.
Via
Talk Markets
Alkermes Stock Sees Rising Relative Price Strength
February 17, 2023
The Relative Strength (RS) Rating for Alkermes stock entered a new percentile Friday, with an increase from 79 to 86.
Via
Investor's Business Daily
Seattle Genetics' 'Refreshing' Enthusiasm Drives Stock Surge; Alkermes Briefly Breaks Out
February 16, 2023
Seattle Genetics' guidance deliberately excludes a looming opportunity for Padcev.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.